- Date of occurrence of the event: Mar 13, 2020
- Company name: OBI Pharma Inc.
- Relationship to the Company (please enter “head office” or “subsidiaries”): Head office
- Reciprocal shareholding ratios: Not applicable
- Cause of occurrence:
The 2019 Individual/Consolidated Financial Statement, detailed as below:
Individual Financial Statement:
Operating loss: (1,321,659) thousand dollars
Total comprehensive loss for the period: (1,408,001) thousand dollars
Loss Per Share (in dollars): (7.76) dollars
Consolidated Financial Statement:
Operating loss: (1,450,861) thousand dollars
Total comprehensive loss for the period: (1,440,565) thousand dollars
Loss Per Share (in dollars): (7.76) dollars - Countermeasures: Not applicable
- Any other matters that need to be specified: None